Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-011938)

Filing Details

Accession Number:: 0001209191-18-011938
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-21 16:32:43
Reporting Period:: 2018-02-16

Accepted Time:: 2018-02-21 16:32:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516551	Nemus Bioscience Inc.	NMUS	Pharmaceutical Preparations (2834)	450692882

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1728413	Emerald Health Sciences Inc.	Office 8262, The Landing 200 - 375 Water St. Vancouver A1 V6B 0M9		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-02-16	15,000,000	$0.00	39,000,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2018-02-16	20,400,000	$0.00	20,400,000	$0.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,400,000	2018-02-16	2023-02-16	No	4	P	Direct

Footnotes

The reporting person purchased in a private placement 15,000,000 shares (the "Shares") of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), and a warrant (the "Warrant") to purchase 20,400,000 shares of Common Stock at an exercise price of $0.10 per share. The Shares and the Warrant were purchased as a unit at $.10 per unit.